HealthQuest Capital has announced it has raised $110 million for its debut fund.
HealthQuest Capital (HQC) is a Menlo Park, Calif.-based fund sponsored by Sofinnova Ventures.
HQC indicated it will focus investments in the medical device, diagnostics, patient care products, consumer health/OTC and healthcare IT fields, with a primary focus on commercial stage investments, providing capital towards growing revenues and scaling existing businesses in promising sectors.
HQC's initial portfolio includes Vestagen, First Aid Shot Therapy and Castle Biosciences.
Originally published in Healthcare Services Investing
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
[View Source]